Insulin Lispro, Recombinant Dna Derived Containing 100 Iu/Ml, 3Ml Pen - 3,600 Units

Name: Insulin Lispro, Recombinant Dna Derived Containing 100 Iu/Ml, 3Ml Pen - 3,600 Units
Start: 2024-11-22
End: 2024-12-06
Location: Superintendencia de Assistencia Farmaceutica, Ciencia e Tecnologia em Saude

Superintendencia de Assistencia Farmaceutica, Ciencia e Tecnologia em Saude Brazil has Released a tender for Insulin Lispro, Recombinant Dna Derived Containing 100 Iu/Ml, 3Ml Pen - 3,600 Units in Healthcare and Medicine. The tender was released on Nov 21, 2024.

Country - Brazil

Summary - Insulin Lispro, Recombinant Dna Derived Containing 100 Iu/Ml, 3Ml Pen - 3,600 Units

Deadline - Dec 06, 2024

GT reference number - 98023387

Product classification - Medical equipments, pharmaceuticals and personal care products

Organization Details:

Address - Brazil

Contact details - 565656565

Tender notice no. - 76454545

GT Ref Id - 98023387

Document Type - Tender Notices

Notice Details and Documents:

Description - notice_title: * Electronic Bidding * Insulin Lispro, Recombinant Dna Derived Containing 100 Iu/Ml, 3Ml Pen - 3,600 Unitslocal title:: * Licitação Eletrônica * INSULINA LISPRO, DERIVADA DE ADN RECOMBINANTE CONTENDO 100 UI/ML, CANETA 3ML - 3.600 uni dades

Gt Ref Id - 98023387

Deadline - Dec 06, 2024

View more tenders for

Medical equipments, pharmaceut Tenders Brazil Tenders

Similar Tenders :

Create Account

Join to access thousands of business opportunities

Quick Links

Why Us

3,00,000 +

Users

190 +

Countries Covered

5,00,000 +

Agencies Tracked

50,000 +

Notices Daily

90 Million +

Database